Last edition
News about "As US FDA lifts clinical hold, Covaxin to be evalu"
As US FDA lifts clinical hold, Covaxin to be evaluated as COVID-19 vaccine candidate in US
Covaxin (BBVI52), which has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is an investigational vaccine candidate product in the US
As US FDA Lifts Clinical Hold, Covaxin To Be Evalu | 22/02/2022 | By Darshana | 244
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members